Bill Text: IL SB3614 | 2017-2018 | 100th General Assembly | Introduced

---

Bill Title: Amends the University of Illinois Hospital Act. Provides that the Board of Trustees of the University of Illinois shall require all pharmaceutical manufacturers that have contracts with the University of Illinois Hospital to submit an annual report to the Board of Trustees of the University of Illinois and the Illinois Health Facilities and Services Review Board, by April 15, 2019 and every April 15 thereafter, in a searchable Adobe PDF format, on all procurement goals and actual spending for women-owned, minority-owned, veteran-owned, and small business enterprises in the previous calendar year. Provides that the goals shall be expressed as a percentage of the total work performed by the entity submitting the report, and the actual spending for all women-owned, minority-owned, veteran-owned, and small business enterprises shall also be expressed as a percentage of the total work performed by the entity submitting the report. Provides that the annual report must contain specified information. Provides that beginning April 15, 2019, no contract, oral or written, shall be awarded by the Board of Trustees of the University of Illinois to a pharmaceutical manufacturer without first requiring the pharmaceutical manufacturer to make specified disclosures. Defines "pharmaceutical manufacturer" and "prescription drug". Provides that the Illinois Health Facilities and Services Review Board shall publish each annual report on its website and shall maintain each annual report for at least 5 years. Effective January 1, 2019.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Failed) 2019-01-09 - Session Sine Die [SB3614 Detail]

Download: Illinois-2017-SB3614-Introduced.html

---

100TH GENERAL ASSEMBLY State of Illinois 2017 and 2018 SB3614 Introduced 5/22/2018, by Sen. James F. Clayborne, Jr. SYNOPSIS AS INTRODUCED:
110 ILCS 330/8b new
Amends the University of Illinois Hospital Act. Provides that the Board of Trustees of the University of Illinois shall require all pharmaceutical manufacturers that have contracts with the University of Illinois Hospital to submit an annual report to the Board of Trustees of the University of Illinois and the Illinois Health Facilities and Services Review Board, by April 15, 2019 and every April 15 thereafter, in a searchable Adobe PDF format, on all procurement goals and actual spending for women-owned, minority-owned, veteran-owned, and small business enterprises in the previous calendar year. Provides that the goals shall be expressed as a percentage of the total work performed by the entity submitting the report, and the actual spending for all women-owned, minority-owned, veteran-owned, and small business enterprises shall also be expressed as a percentage of the total work performed by the entity submitting the report. Provides that the annual report must contain specified information. Provides that beginning April 15, 2019, no contract, oral or written, shall be awarded by the Board of Trustees of the University of Illinois to a pharmaceutical manufacturer without first requiring the pharmaceutical manufacturer to make specified disclosures. Defines "pharmaceutical manufacturer" and "prescription drug". Provides that the Illinois Health Facilities and Services Review Board shall publish each annual report on its website and shall maintain each annual report for at least 5 years. Effective January 1, 2019.
LRB100 22100 RPS 40392 b
FISCAL NOTE ACT MAY APPLY
A BILL FOR
SB3614 LRB100 22100 RPS 40392 b
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The University of Illinois Hospital Act is
amended by adding Section 8b as follows:
(110 ILCS 330/8b new)
Sec. 8b. Pharmaceutical manufacturer diversity goals.
(a) The public policy of this State is to collaboratively
work with companies that serve Illinois residents to improve
their supplier diversity in a non-antagonistic manner.
(b) As used in this Section:
"Pharmaceutical manufacturer" includes:
(1) An entity that is engaged in (a) the production,
preparation, propagation, compounding, conversion, or
processing of prescription drug products (i) directly or
indirectly by extraction from substances of natural
origin, (ii) independently by means of chemical synthesis,
or (iii) by combination of extraction and chemical
synthesis; or (b) the packaging, repackaging, labeling or
re-labeling, or distribution of prescription drug
products.
(2) The entity holding legal title to or possession of
the national drug code number for the covered prescription

SB3614 - 2 - LRB100 22100 RPS 40392 b
drug.
"Pharmaceutical manufacturer" does not include a wholesale
distributor of drugs, drugstore chain organization, or retail
pharmacy licensed by the State.
"Prescription drug" means a drug that may be dispensed only
upon prescription by an authorized prescriber and that is
approved for safety and effectiveness as a prescription drug
under Section 505 or 507 of the Federal Food, Drug, and
Cosmetic Act.
(c) The Board of Trustees of the University of Illinois
shall require all pharmaceutical manufacturers that have
contracts with the University of Illinois Hospital to submit an
annual report to the Board of Trustees of the University of
Illinois and the Illinois Health Facilities and Services Review
Board, by April 15, 2019 and every April 15 thereafter, in a
searchable Adobe PDF format, on all procurement goals and
actual spending for women-owned, minority-owned,
veteran-owned, and small business enterprises in the previous
calendar year. These goals shall be expressed as a percentage
of the total work performed by the entity submitting the
report, and the actual spending for all women-owned,
minority-owned, veteran-owned, and small business enterprises
shall also be expressed as a percentage of the total work
performed by the entity submitting the report.
(d) Each pharmaceutical manufacturer in its annual report
shall include the following information:

SB3614 - 3 - LRB100 22100 RPS 40392 b
(1) an explanation of the plan for the next year to
increase participation;
(2) an explanation of the plan to increase the goals;
(3) the areas of procurement each pharmaceutical
manufacturer will be actively seeking more participation
in in the next year;
(4) an outline of the plan to alert and encourage
potential vendors in that area to seek business from the
pharmaceutical manufacturer;
(5) an explanation of the challenges faced in finding
quality vendors and offer any suggestions for what the
Board of Trustees of the University of Illinois could do to
be helpful to identify those vendors;
(6) a list of the certifications the pharmaceutical
manufacturer recognizes;
(7) the point of contact for any potential vendor who
wishes to do business with the pharmaceutical manufacturer
and an explanation of the process for a vendor to enroll
with the company as a minority-owned, women-owned, or
veteran-owned company; and
(8) any particular success stories to encourage other
pharmaceutical manufacturers to emulate best practices.
(e) Each annual report shall include as much State-specific
data as possible. If the pharmaceutical manufacturer does not
submit State-specific data, then the pharmaceutical
manufacturer shall include any national data it does have and

SB3614 - 4 - LRB100 22100 RPS 40392 b
explain why it could not submit State-specific data and how it
intends to do so in future reports, if possible.
(f) Each annual report shall include the rules,
regulations, and definitions used for the procurement goals in
the pharmaceutical manufacturer's annual report.
(g) The Illinois Health Facilities and Services Review
Board shall publish each annual report on its website and shall
maintain each annual report for at least 5 years.
(h) Beginning April 15, 2019, no contract, oral or written,
shall be awarded by the Board of Trustees of the University of
Illinois to a pharmaceutical manufacturer without first
requiring the pharmaceutical manufacturer to make the
disclosures required in subsection (c).
Section 99. Effective date. This Act takes effect January
1, 2019.